The report focuses on the Immuno-Oncology market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Immuno-Oncology market.
Major Players in the Immuno-Oncology market are:
Sanofi S.A.
Eli Lilly and Company
EMD Serono
Gilead Sciences Inc.
Bristol-Myers Squibb
Galena Biopharma
Merck & Co.
ImmunoCellular Therapeutics
Bavarian Nordic
AbbVie
AstraZeneca, Plc
Celgene Corporation
Johnson & Johnson
Incyte
Celldex Therapeutics
Amgen, Inc
Aduro BioTech
Prometheus Therapeutics & Diagnostics
Pfizer Inc.
Hoffmann-La Roche AG
Novartis International AG
On the basis of types, the Immuno-Oncology market is primarily split into:
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
On the basis of applications, the market covers:
Hospitals
Clinics
Ambulatory Surgical Centers
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Immuno-Oncology Market Overview
1.1 Product Overview and Scope of Immuno-Oncology Market
1.2 Immuno-Oncology Market Segment by Type
1.2.1 Global Immuno-Oncology Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Immuno-Oncology Market Segment by Application
1.3.1 Immuno-Oncology Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Immuno-Oncology Market, Region Wise (2017-2029)
1.4.1 Global Immuno-Oncology Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2029)
1.4.2 United States Immuno-Oncology Market Status and Prospect (2017-2029)
1.4.3 Europe Immuno-Oncology Market Status and Prospect (2017-2029)
1.4.4 China Immuno-Oncology Market Status and Prospect (2017-2029)
1.4.5 Japan Immuno-Oncology Market Status and Prospect (2017-2029)
1.4.6 India Immuno-Oncology Market Status and Prospect (2017-2029)
1.4.7 Southeast Asia Immuno-Oncology Market Status and Prospect (2017-2029)
1.4.8 Latin America Immuno-Oncology Market Status and Prospect (2017-2029)
1.4.9 Middle East and Africa Immuno-Oncology Market Status and Prospect (2017-2029)
1.5 Global Market Size (Revenue) of Immuno-Oncology (2017-2029)
1.5.1 Global Immuno-Oncology Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Immuno-Oncology Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Immuno-Oncology Industry
1.7 Impact of Carbon Neutrality on the Immuno-Oncology Industry
2 Immuno-Oncology Market Upstream and Downstream Analysis
2.1 Immuno-Oncology Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Immuno-Oncology Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Sanofi S.A.
3.1.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Immuno-Oncology Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Eli Lilly and Company
3.2.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Immuno-Oncology Market Performance (2017-2022)
3.2.4 Business Overview
3.3 EMD Serono
3.3.1 EMD Serono Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Immuno-Oncology Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Gilead Sciences Inc.
3.4.1 Gilead Sciences Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Immuno-Oncology Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Bristol-Myers Squibb
3.5.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Immuno-Oncology Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Galena Biopharma
3.6.1 Galena Biopharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Immuno-Oncology Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Merck & Co.
3.7.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Immuno-Oncology Market Performance (2017-2022)
3.7.4 Business Overview
3.8 ImmunoCellular Therapeutics
3.8.1 ImmunoCellular Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Immuno-Oncology Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Bavarian Nordic
3.9.1 Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Immuno-Oncology Market Performance (2017-2022)
3.9.4 Business Overview
3.10 AbbVie
3.10.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Immuno-Oncology Market Performance (2017-2022)
3.10.4 Business Overview
3.11 AstraZeneca, Plc
3.11.1 AstraZeneca, Plc Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Immuno-Oncology Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Celgene Corporation
3.12.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Immuno-Oncology Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Johnson & Johnson
3.13.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Immuno-Oncology Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Incyte
3.14.1 Incyte Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Immuno-Oncology Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Celldex Therapeutics
3.15.1 Celldex Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Immuno-Oncology Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Amgen, Inc
3.16.1 Amgen, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Immuno-Oncology Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Aduro BioTech
3.17.1 Aduro BioTech Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Immuno-Oncology Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Prometheus Therapeutics & Diagnostics
3.18.1 Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Immuno-Oncology Market Performance (2017-2022)
3.18.4 Business Overview
3.19 Pfizer Inc.
3.19.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Immuno-Oncology Market Performance (2017-2022)
3.19.4 Business Overview
3.20 Hoffmann-La Roche AG
3.20.1 Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Immuno-Oncology Market Performance (2017-2022)
3.20.4 Business Overview
3.21 Novartis International AG
3.21.1 Novartis International AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 Immuno-Oncology Market Performance (2017-2022)
3.21.4 Business Overview
4 Global Immuno-Oncology Market Landscape by Player
4.1 Global Immuno-Oncology Sales and Share by Player (2017-2022)
4.2 Global Immuno-Oncology Revenue and Market Share by Player (2017-2022)
4.3 Global Immuno-Oncology Average Price by Player (2017-2022)
4.4 Global Immuno-Oncology Gross Margin by Player (2017-2022)
4.5 Immuno-Oncology Market Competitive Situation and Trends
4.5.1 Immuno-Oncology Market Concentration Rate
4.5.2 Immuno-Oncology Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Immuno-Oncology Sales, Revenue, Price Trend by Type
5.1 Global Immuno-Oncology Sales and Market Share by Type (2017-2022)
5.2 Global Immuno-Oncology Revenue and Market Share by Type (2017-2022)
5.3 Global Immuno-Oncology Price by Type (2017-2022)
5.4 Global Immuno-Oncology Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Immuno-Oncology Sales, Revenue and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
5.4.2 Global Immuno-Oncology Sales, Revenue and Growth Rate of Immune System Modulators (2017-2022)
5.4.3 Global Immuno-Oncology Sales, Revenue and Growth Rate of Cancer Vaccines (2017-2022)
5.4.4 Global Immuno-Oncology Sales, Revenue and Growth Rate of Oncolytic Virus (2017-2022)
6 Global Immuno-Oncology Market Analysis by Application
6.1 Global Immuno-Oncology Consumption and Market Share by Application (2017-2022)
6.2 Global Immuno-Oncology Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Immuno-Oncology Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Immuno-Oncology Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Immuno-Oncology Consumption and Growth Rate of Clinics (2017-2022)
6.3.3 Global Immuno-Oncology Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
7 Global Immuno-Oncology Sales and Revenue Region Wise (2017-2022)
7.1 Global Immuno-Oncology Sales and Market Share, Region Wise (2017-2022)
7.2 Global Immuno-Oncology Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States Immuno-Oncology Market Under COVID-19
7.5 Europe Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe Immuno-Oncology Market Under COVID-19
7.6 China Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China Immuno-Oncology Market Under COVID-19
7.7 Japan Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan Immuno-Oncology Market Under COVID-19
7.8 India Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India Immuno-Oncology Market Under COVID-19
7.9 Southeast Asia Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia Immuno-Oncology Market Under COVID-19
7.10 Latin America Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America Immuno-Oncology Market Under COVID-19
7.11 Middle East and Africa Immuno-Oncology Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa Immuno-Oncology Market Under COVID-19
8 Global Immuno-Oncology Market Forecast (2022-2029)
8.1 Global Immuno-Oncology Sales, Revenue Forecast (2022-2029)
8.1.1 Global Immuno-Oncology Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Immuno-Oncology Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Immuno-Oncology Price and Trend Forecast (2022-2029)
8.2 Global Immuno-Oncology Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.2.3 China Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.2.5 India Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Immuno-Oncology Sales and Revenue Forecast (2022-2029)
8.3 Global Immuno-Oncology Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Immuno-Oncology Revenue and Growth Rate of Immune Checkpoint Inhibitors (2022-2029)
8.3.2 Global Immuno-Oncology Revenue and Growth Rate of Immune System Modulators (2022-2029)
8.3.3 Global Immuno-Oncology Revenue and Growth Rate of Cancer Vaccines (2022-2029)
8.3.4 Global Immuno-Oncology Revenue and Growth Rate of Oncolytic Virus (2022-2029)
8.4 Global Immuno-Oncology Consumption Forecast by Application (2022-2029)
8.4.1 Global Immuno-Oncology Consumption Value and Growth Rate of Hospitals (2022-2029)
8.4.2 Global Immuno-Oncology Consumption Value and Growth Rate of Clinics (2022-2029)
8.4.3 Global Immuno-Oncology Consumption Value and Growth Rate of Ambulatory Surgical Centers (2022-2029)
8.5 Immuno-Oncology Market Forecast Under COVID-19
9 Industry Outlook
9.1 Immuno-Oncology Market Drivers Analysis
9.2 Immuno-Oncology Market Restraints and Challenges
9.3 Immuno-Oncology Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Immuno-Oncology Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Immuno-Oncology Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Immuno-Oncology Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
?
List of Tables and Figures
Figure Immuno-Oncology Product Picture
Table Global Immuno-Oncology Market Sales and CAGR (%) Comparison by Type
Table Profile of Immune Checkpoint Inhibitors
Table Profile of Immune System Modulators
Table Profile of Cancer Vaccines
Table Profile of Oncolytic Virus
Table Immuno-Oncology Market Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Hospitals
Table Profile of Clinics
Table Profile of Ambulatory Surgical Centers
Figure Global Immuno-Oncology Market Size (Revenue, Million USD) and CAGR (%) (2017-2029)
Figure United States Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure Europe Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure China Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure Japan Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure India Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure Southeast Asia Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure Latin America Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure Middle East and Africa Immuno-Oncology Market Revenue (Million USD) and Growth Rate (2017-2029)
Figure Global Immuno-Oncology Market Sales Status and Outlook (2017-2029)
Figure Immuno-Oncology Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Table Downstream Buyers
Table Sanofi S.A. Profile
Table Sanofi S.A. Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Sales and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly and Company Sales and Growth Rate
Figure Eli Lilly and Company Revenue (Million USD) Market Share 2017-2022
Table EMD Serono Profile
Table EMD Serono Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure EMD Serono Sales and Growth Rate
Figure EMD Serono Revenue (Million USD) Market Share 2017-2022
Table Gilead Sciences Inc. Profile
Table Gilead Sciences Inc. Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gilead Sciences Inc. Sales and Growth Rate
Figure Gilead Sciences Inc. Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Sales and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table Galena Biopharma Profile
Table Galena Biopharma Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Galena Biopharma Sales and Growth Rate
Figure Galena Biopharma Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Sales and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table ImmunoCellular Therapeutics Profile
Table ImmunoCellular Therapeutics Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ImmunoCellular Therapeutics Sales and Growth Rate
Figure ImmunoCellular Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Bavarian Nordic Profile
Table Bavarian Nordic Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bavarian Nordic Sales and Growth Rate
Figure Bavarian Nordic Revenue (Million USD) Market Share 2017-2022
Table AbbVie Profile
Table AbbVie Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Sales and Growth Rate
Figure AbbVie Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca, Plc Profile
Table AstraZeneca, Plc Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca, Plc Sales and Growth Rate
Figure AstraZeneca, Plc Revenue (Million USD) Market Share 2017-2022
Table Celgene Corporation Profile
Table Celgene Corporation Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Sales and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Sales and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Incyte Profile
Table Incyte Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Incyte Sales and Growth Rate
Figure Incyte Revenue (Million USD) Market Share 2017-2022
Table Celldex Therapeutics Profile
Table Celldex Therapeutics Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celldex Therapeutics Sales and Growth Rate
Figure Celldex Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Amgen, Inc Profile
Table Amgen, Inc Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen, Inc Sales and Growth Rate
Figure Amgen, Inc Revenue (Million USD) Market Share 2017-2022
Table Aduro BioTech Profile
Table Aduro BioTech Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aduro BioTech Sales and Growth Rate
Figure Aduro BioTech Revenue (Million USD) Market Share 2017-2022
Table Prometheus Therapeutics & Diagnostics Profile
Table Prometheus Therapeutics & Diagnostics Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Prometheus Therapeutics & Diagnostics Sales and Growth Rate
Figure Prometheus Therapeutics & Diagnostics Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Sales and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Hoffmann-La Roche AG Profile
Table Hoffmann-La Roche AG Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Hoffmann-La Roche AG Sales and Growth Rate
Figure Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Novartis International AG Profile
Table Novartis International AG Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis International AG Sales and Growth Rate
Figure Novartis International AG Revenue (Million USD) Market Share 2017-2022
Table Global Immuno-Oncology Sales by Player (2017-2022)
Table Global Immuno-Oncology Sales Share by Player (2017-2022)
Figure Global Immuno-Oncology Sales Share by Player in 2021
Table Immuno-Oncology Revenue (Million USD) by Player (2017-2022)
Table Immuno-Oncology Revenue (Million USD) Market Share by Player (2017-2022)
Table Immuno-Oncology Price by Player (2017-2022)
Table Immuno-Oncology Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Immuno-Oncology Sales by Type (2017-2022)
Table Global Immuno-Oncology Sales Market Share by Type (2017-2022)
Figure Global Immuno-Oncology Sales Market Share by Type in 2021
Table Global Immuno-Oncology Revenue (Million USD) by Type (2017-2022)
Table Global Immuno-Oncology Revenue Market Share by Type (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share by Type in 2021
Table Immuno-Oncology Price by Type (2017-2022)
Figure Global Immuno-Oncology Sales and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-Oncology Sales and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-Oncology Sales and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-Oncology Sales and Growth Rate of Oncolytic Virus (2017-2022)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2017-2022)
Table Global Immuno-Oncology Consumption by Application (2017-2022)
Table Global Immuno-Oncology Consumption Market Share by Application (2017-2022)
Table Global Immuno-Oncology Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Immuno-Oncology Consumption Revenue Market Share by Application (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Clinics (2017-2022)
Table Global Immuno-Oncology Consumption and Growth Rate of Ambulatory Surgical Centers (2017-2022)
Table Global Immuno-Oncology Sales, Region Wise (2017-2022)
Table Global Immuno-Oncology Sales Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Sales Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Sales Market Share, Region Wise in 2021
Table Global Immuno-Oncology Revenue (Million USD), Region Wise (2017-2022)
Table Global Immuno-Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-Oncology Revenue Market Share, Region Wise in 2021
Table Global Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Immuno-Oncology Sales, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Global Immuno-Oncology Sales and Growth Rate Forecast (2022-2029)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate Forecast (2022-2029)
Figure Global Immuno-Oncology Price and Trend Forecast (2022-2029)
Figure USA Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure USA Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Figure China Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure China Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Figure India Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure India Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Immuno-Oncology Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Immuno-Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2029)
Table Global Immuno-Oncology Market Sales Forecast, by Type
Table Global Immuno-Oncology Sales Volume Market Share Forecast, by Type
Table Global Immuno-Oncology Market Revenue (Million USD) Forecast, by Type
Table Global Immuno-Oncology Revenue Market Share Forecast, by Type
Table Global Immuno-Oncology Price Forecast, by Type
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2029)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2029)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2029)
Figure Global Immuno-Oncology Revenue (Million USD) and Growth Rate of Oncolytic Virus (2022-2029)
Table Global Immuno-Oncology Market Consumption Forecast, by Application
Table Global Immuno-Oncology Consumption Volume Market Share Forecast, by Application
Table Global Immuno-Oncology Market Revenue (Million USD) Forecast, by Application
Table Global Immuno-Oncology Revenue Market Share Forecast, by Application
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2029)
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Clinics (2022-2029)
Figure Global Immuno-Oncology Consumption Value (Million USD) and Growth Rate of Ambulatory Surgical Centers (2022-2029)
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Immuno-Oncology Industry Development